Piramal Pharma (BOM:543635) Long-Term Debt : ₹24,838 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Long-Term Debt?

Piramal Pharma's Long-Term Debt for the quarter that ended in Mar. 2024 was ₹24,838 Mil.

Piramal Pharma's quarterly Long-Term Debt declined from Sep. 2023 (₹28,611 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹24,838 Mil).

Piramal Pharma's annual Long-Term Debt increased from Mar. 2022 (₹26,221 Mil) to Mar. 2023 (₹33,835 Mil) but then declined from Mar. 2023 (₹33,835 Mil) to Mar. 2024 (₹24,838 Mil).

Piramal Pharma Long-Term Debt Historical Data

The historical data trend for Piramal Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Long-Term Debt Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

26,221.40

33,835.40

24,837.50

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial							33,835.40	-	28,611.40	-	24,837.50

Piramal Pharma (BOM:543635) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Piramal Pharma Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (BOM:543635) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (BOM:543635) » Definitions » Long-Term Debt

Traded in Other Exchanges

PPLPHARMA:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (BOM:543635) Headlines

No Headlines